UK’s NICE recently released its guidelines, which will effectively determine the extent of medical cannabis access on the NHS.

Europe’s patchwork of medical cannabis reforms has prevented formation of a harmonised supply chain model.

UK’s NICE recently released its draft guidelines, which will effectively determine the extent of medical cannabis access on the NHS.

We were very proud to bring Cannabis Europa back to London this June.

The Irish government announced its plans for a five year medical cannabis access pilot programme. What will this mean, in practice, for people living in Ireland?

There's an unmistakable odour causing quite a stir among the writers of The Spectator. 

As a variety cannabis products are introduced into the medical field, both industry and institutions are facing the challenges of a new, rapidly-evolving policy environment being built on the backbone of an old and strained system of medical regulations.

The French National Agency for Medicines and Health Products Safety, ANSM, recommended last Thursday the implementation of a medical cannabis regime in France.

The UK government has laid historic new regulations rescheduling cannabis-based medicine, which will come into force on 1st November 2018.

The French Agency for Medicines and Healthcare Products Safety (ANSM) has published the list of the members who will make up the Special Committee charged with the review of medical cannabis benefits in France.

On September 21st the UK government announced how they would define cannabis-based products for medicinal use. Following the conclusion of the two part review by the Chief Medical Officer and the ACMD on July 25th, Home Secretary Sajid Javid committed to swift action on the matter, and promised that these products would be lawful by autumn.

On Monday 10th September, the National Agency for Health and Medicines (ANSM) announced the creation of a special committee to review the evidence supporting the effectiveness of medical cannabis.

This is the first in a blog series profiling exciting companies, projects and people who are paving the way in the UK cannabis space. Separating The Strains is a documentary, currently in production, that explores medical cannabis treatments for epilepsy patients and others. 

Over the next 6 ½ weeks in the build up to the conference we will be making a series of exciting announcements including a raft of new speakers, sponsors and events.